Antiarrhythmic Drug Therapy: Where Do We Go From Here?

被引：6

作者：

Kowey, Peter R. ^{[1
,2
]}

Naccarelli, Gerald V. ^{[3
]}

机构：

[1] Thomas Jefferson Univ, Philadelphia, PA USA

[2] Lankenau Hearth Inst, Wynnewood, PA USA

[3] Penn State Heart & Vasc Inst, Penn State Hlth Milton S Hershey Med Ctr, Vasc Surg, Hershey, PA 17033 USA

来源：

CIRCULATION | 2024年 / 149卷 / 11期

关键词：

anti-arrhythmia agents; arrhythmias; atrial fibrillation;

D O I：

10.1161/CIRCULATIONAHA.123.066989

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：801 / 803

页数：3

共 5 条

[1] MORTALITY AND MORBIDITY IN PATIENTS RECEIVING ENCAINIDE, FLECAINIDE, OR PLACEBO - THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL [J].

ECHT, DS ;

LIEBSON, PR ;

MITCHELL, LB ;

PETERS, RW ;

OBIASMANNO, D ;

BARKER, AH ;

ARENSBERG, D ;

BAKER, A ;

FRIEDMAN, L ;

GREENE, HL ;

HUTHER, ML ;

RICHARDSON, DW .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (12) :781-788

[2] The Relentless Pursuit of New Drugs to Treat Cardiac Arrhythmias [J].

Kowey, Peter R. ;

Robinson, Victoria M. .

CIRCULATION, 2020, 141 (19) :1507-1509

[3] Are Class IC Antiarrhythmic Agents Safe in Atrial Fibrillation Patients With Nonobstructive Coronary Artery Disease? [J].

Naccarelli, Gerald V. .

JACC-CLINICAL ELECTROPHYSIOLOGY, 2023, 9 (07) :1181-1183

[4] Dronedarone [J].

Patel, Chinmay ;

Yan, Gan-Xin ;

Kowey, Peter R. .

CIRCULATION, 2009, 120 (07) :636-644

[5] Recent Advances in Antiarrhythmic Drug Therapy [J].

Saljic, Arnela ;

Heijman, Jordi ;

Dobrev, Dobromir .

DRUGS, 2023, 83 (13) :1147-1160

← 1 →